« Back to Record
Citation APA

Bottomley, A., Biganzoli, L., Cufer, T., Coleman, R., Coens, C., Efficace, F., Calvert, H., Gamucci, T., Twelves, C., Fargeot, P., Piccart-Gebhart, M., & European Organization for Research and Treatment of Cancer Breast Cancer Group, (2004). Randomized, controlled trial investigating short-term health-related quality of life with doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: European Organization for Research and Treatment of Cancer Breast Cancer Group, Investigational Drug Branch for Breast Cancer and the New Drug Development Group Study. Journal of clinical oncology, 22(13), 2576-2586. doi:10.1200/JCO.2004.02.037


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/55253

Bottomley, A., Biganzoli, L., Cufer, T., Coleman, R., Coens, C., Efficace, F., Calvert, H., Gamucci, T., Twelves, C., Fargeot, P., Piccart-Gebhart, M., & European Organization for Research and Treatment of Cancer Breast Cancer Group, (2004). Randomized, controlled trial investigating short-term health-related quality of life with doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: European Organization for Research and Treatment of Cancer Breast Cancer Group, Investigational Drug Branch for Breast Cancer and the New Drug Development Group Study. Journal of clinical oncology, 22(13), 2576-2586. doi:10.1200/JCO.2004.02.037